183 related articles for article (PubMed ID: 30788936)
21. The impact of main branch restenosis on long term mortality following drug-eluting stent implantation in patients with de novo unprotected distal left main bifurcation coronary lesions: the Milan and New-Tokyo (MITO) Registry.
Takagi K; Ielasi A; Basavarajaiah S; Chieffo A; Shannon J; Godino C; Hasegawa T; Naganuma T; Fujino Y; Latib A; Carlino M; Montorfano M; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2014 Sep; 84(3):341-8. PubMed ID: 24038911
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Predictive Value of CHA
Yilmaz S; Akboga MK; Aras D; Topaloglu S
Angiology; 2018 Jan; 69(1):38-42. PubMed ID: 28345395
[TBL] [Abstract][Full Text] [Related]
23. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
24. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
Araki T; Nakamura M; Sugi K
J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
[TBL] [Abstract][Full Text] [Related]
25. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
Wu XA; Xie G; Li XQ; Wu HT; Wang X
Clin Chim Acta; 2018 Apr; 479():20-24. PubMed ID: 29305846
[TBL] [Abstract][Full Text] [Related]
26. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
27. Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
Hee L; Terluk A; Thomas L; Hopkins A; Juergens CP; Lo S; French JK; Mussap CJ
Catheter Cardiovasc Interv; 2017 Feb; 89(3):375-382. PubMed ID: 27113534
[TBL] [Abstract][Full Text] [Related]
28. Impaired Peripheral Endothelial Function Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis.
Komura N; Tsujita K; Yamanaga K; Sakamoto K; Kaikita K; Hokimoto S; Iwashita S; Miyazaki T; Akasaka T; Arima Y; Yamamoto E; Izumiya Y; Yamamuro M; Kojima S; Tayama S; Sugiyama S; Matsui K; Nakamura S; Hibi K; Kimura K; Umemura S; Ogawa H
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317348
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNA-21 as Stable Blood-Based Markers for Patients With ISR After PCI.
Zhang X; Xiao XP; Ren XA; Xue W
Heart Surg Forum; 2020 Oct; 23(6):E756-E762. PubMed ID: 33234202
[TBL] [Abstract][Full Text] [Related]
30. Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions.
Balli M; Taşolar H; Çetin M; Tekin K; Çağliyan ÇE; Türkmen S; Yilmaz M; Elbasan Z; Şahin DY; Çayli M
Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1866-73. PubMed ID: 26044233
[TBL] [Abstract][Full Text] [Related]
31. Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.
Hu CP; Du Y; Zhu Y; Shi C; Qin Z; Zhao YX
Chin Med J (Engl); 2018 Apr; 131(7):757-763. PubMed ID: 29578117
[TBL] [Abstract][Full Text] [Related]
32. Myocardial Injury after Percutaneous Coronary Intervention for In-Stent Restenosis Versus de novo Stenosis.
Shimonaga T; Kurisu S; Watanabe N; Ikenaga H; Higaki T; Iwasaki T; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
Intern Med; 2015; 54(18):2299-305. PubMed ID: 26370852
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
[No Abstract] [Full Text] [Related]
34. Comparison of clinical outcomes between percutaneous coronary intervention for de novo lesions versus in-stent restenosis lesions.
Takeuchi M; Dohi T; Fukase T; Nishio R; Takahashi N; Endo H; Doi S; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Minamino T
Cardiovasc Interv Ther; 2022 Apr; 37(2):324-332. PubMed ID: 34224098
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Nutritional Index as a Novel Predictor of In-Stent Restenosis: A Retrospective Study.
Balun A; Akgümüş A; Özbek K; Güven Çetin Z
Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109621
[No Abstract] [Full Text] [Related]
36. Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Yıldırım E; Çelik M; Yüksel UÇ; Buğan B; Gökoğlan Y; Görmel S; Yaşar S; Koklu M; İyisoy A; Barçın C
Turk Kardiyol Dern Ars; 2017 Dec; 45(8):702-708. PubMed ID: 29226890
[TBL] [Abstract][Full Text] [Related]
37. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
38. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
39. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
Liu J; Liu Y; Jia K; Huo Z; Huo Q; Liu Z; Li Y; Han X; Wang R
Medicine (Baltimore); 2018 Apr; 97(17):e0366. PubMed ID: 29702981
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
Spadaccio C; Patti G; De Marco F; Coccia R; Di Domenico F; Pollari F; Zanzonico R; Pettinari M; Lusini M; Di Sciascio G; Covino E; Chello M
Am J Cardiol; 2013 Jul; 112(1):21-6. PubMed ID: 23561587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
